Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: Predicting HIF-2α Levels in Clear Cell Kidney Cancer Using Machine Learning

View source ↗

Summary

A clinical trial from the First Affiliated Hospital of Fujian Medical University aims to predict HIF-2α levels in renal cell carcinoma (clear cell type) using m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Renal Clear Cell Carcinoma, HIF-2α | Status: ACTIVE_NOT_RECRUITING